“Grants approval” can mean three different things depending on who’s asking, and confusing them is a common source of missed deadlines. This guide covers the one research administrators deal with most often and that has the least dedicated coverage elsewhere: the institutional approval process a grant proposal goes through before it ever reaches a funder — the internal routing, sign-off, and certification chain that has to close out before a Sponsored Programs Office will submit anything on an institution’s behalf.
Before going further, it’s worth being explicit about the other two things “grant approval” commonly refers to, since a reader could mean any of them:
- Institutional (internal) approval — the subject of this guide: department, college, and central-office sign-off on a proposal before it’s submitted to a sponsor.
- Funder (external) approval — the sponsor’s own decision to fund a submitted application, communicated via a Notice of Award-type document (NIH) or an award letter (NSF, most foundations). See CASRAI’s NIH Grants overview and NSF Grants overview for how each agency structures that decision.
- Ethics/compliance approval — IRB, IACUC, biosafety, or export-control sign-off on the human-subjects, animal, or dual-use aspects of a specific project. This is a prerequisite input into the institutional approval process covered here, not a substitute for it — a study can have IRB approval and still be blocked from submission if its budget or COI disclosures haven’t cleared internal review, or vice versa.
What institutional grant approval actually is
Every US research institution that accepts sponsored funding designates an Authorized Organizational Representative (AOR) — called a Signing Official (SO) in NIH’s eRA Commons — as the only person legally empowered to submit a proposal or accept an award on the institution’s behalf. A principal investigator (PI) cannot submit directly to a sponsor as an individual; the institution, through its AOR/SO, is the actual applicant of record for most sponsored awards, even though the PI does the scientific work. Grants.gov and NIH’s eRA Commons both structure their submission systems around this PI-plus-AOR/SO pairing, and neither will release a submission to the sponsor without the AOR/SO’s electronic sign-off.
“Grants approval,” in the internal-routing sense, is the chain of reviews and sign-offs an institution runs between a PI finishing a proposal draft and the AOR/SO releasing it to the sponsor. It exists to protect the institution, not just the PI: an AOR’s signature is a legal certification that the institution stands behind the budget, the compliance representations, and the terms the PI is proposing to accept.
The typical approval chain
Exact structure varies by institution size and org chart, but most research institutions route a proposal through some version of this sequence before it reaches the AOR/SO:
- Principal Investigator — assembles the scientific narrative, budget, and required ancillary documents (biosketches, current-and-pending/other-support disclosures, data management plan, letters of support).
- Department chair or center director — confirms the PI has appropriate appointment/effort capacity to take on the proposed commitment and that departmental resources (space, cost-share commitments, equipment) referenced in the proposal are real.
- College/school research office (at larger institutions) — a first compliance and budget pass, often where errors get caught early enough to fix before the deadline crunch.
- Sponsored Programs Office / Office of Research — the central review: budget compliance against sponsor and institutional policy (allowable costs, correct F&A rate, cost-sharing commitments), verification that required compliance approvals are in hand or appropriately pending (IRB, IACUC, Conflict of Interest disclosure, export control, biosafety), and confirmation the application package is complete against the sponsor’s own checklist.
- Authorized Organizational Representative / Signing Official — the final legal sign-off and the person who actually releases the submission in Grants.gov Workspace, eRA Commons ASSIST, Research.gov, or the sponsor’s own portal.
Some institutions also run a scientific or strategic internal review at this stage — common where a solicitation caps the number of applications an institution may submit (a “limited submission”) and departments must compete internally for one of a small number of institutional slots before external submission is even possible.
What each level is actually checking for
The review isn’t redundant paperwork at every level — each stage is typically checking something the others can’t:
- Budget compliance — correct indirect-cost rate applied, salaries within any sponsor cap (e.g., the NIH salary cap), cost-sharing commitments that are real and documented, subaward budgets and documentation complete.
- Compliance sign-offs — human-subjects and animal-welfare approvals in hand or on an acceptable “pending” track (many sponsors, including NIH, allow submission before final IRB/IACUC approval but require it before funds are released), current COI disclosures on file for every senior/key person, export-control screening for any foreign collaborators or controlled technology.
- Institutional commitment — that space, matching funds, or cost-sharing pledges referenced in the narrative have actually been authorized by whoever controls them, not just assumed by the PI.
- Completeness against the sponsor’s own submission checklist — missing forms, page-limit or formatting violations, and other administrative errors are the most common reason a technically-sound application gets returned without review, and this is the review layer built to catch them before submission rather than after rejection.
Internal deadlines vs. sponsor deadlines
Because routing involves multiple people who each need time to review, most institutions set an internal submission deadline that falls several business days before the sponsor’s actual due date — the exact lead time is institution-specific (and varies further by whether a limited-submission or non-competing renewal process applies), so check your own Sponsored Programs Office’s published routing calendar rather than assuming a standard figure. Missing the internal deadline doesn’t necessarily mean missing the sponsor’s deadline outright, but it does compress the review window and increases the odds an error gets missed or a compliance approval doesn’t clear in time.
Systems that manage this workflow
Larger institutions rarely route approvals by email alone. Electronic Research Administration (eRA) systems — commercial platforms like Cayuse, InfoEd, and Kuali Research, or an institution’s own build — typically encode this approval chain directly: each reviewer gets a queue, sign-offs are timestamped, and the system won’t let the package move to the AOR/SO’s queue until every prior step is marked complete. See CASRAI’s Grant Management Systems guide for how these platforms differ from a CRIS and what functions they typically cover beyond routing.
What happens after institutional approval
Once the AOR/SO releases the submission, the proposal moves out of institutional control and into the sponsor’s own review pipeline — NIH study section review, an NSF panel, or a foundation’s internal process. Institutional approval says nothing about whether the funder will fund the project; it’s a precondition for eligibility to submit, not a prediction of the outcome. If the sponsor funds it, a formal award document — a Notice of Award at NIH, an award letter or cooperative agreement at other agencies — triggers the award phase and, once accepted, the post-award phase, where an entirely different office and workflow typically takes over. See CASRAI’s Pre-Award vs. Post-Award Office Roles guide for how that handoff works.
Frequently asked questions
Who has legal authority to submit a grant proposal on behalf of a university?
The institution’s Authorized Organizational Representative (AOR), called a Signing Official in NIH’s eRA Commons. A PI drafts and leads the science, but cannot submit as an individual applicant for most sponsored awards — the institution is the actual applicant of record.
Does IRB approval count as “grant approval”?
No. IRB (and IACUC, biosafety, export-control) approvals are compliance prerequisites that feed into the institutional review described above; they are necessary but not sufficient on their own. Many sponsors allow submission before final IRB approval is in hand, on the condition that it’s obtained before funds are released, so a proposal can be institutionally approved and submitted with IRB review still pending.
Is “grant approval” the same as a Notice of Award?
No. A Notice of Award (or equivalent award letter) is the sponsor’s own decision to fund a proposal, issued after submission and external review. Institutional approval happens earlier and only concerns whether the institution will let the proposal go out the door — it has no bearing on whether the sponsor will fund it.
What’s a “limited submission” and how does it affect internal approval?
Some funding opportunities cap the number of applications a single institution may submit. When that happens, institutions typically run an internal competition — departments submit short pre-proposals, and a committee selects which ones proceed to full internal routing and external submission. This adds a scientific-merit step ahead of the compliance/budget review described above.
